FDA Inspection 1200022 — ALBA Bioscience Limited

ALBA Bioscience Limited — FEI 3011683976

The FDA completed an inspection of ALBA Bioscience Limited on March 17, 2023 in Penicuik. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 4 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 17, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Penicuik (United Kingdom)

Citations

IDCFRDescription
313221 CFR 820.120Lack of or inadequate procedures for labeling
367821 CFR 820.30(g)Design Validation - Risk analysis not performed/inadequate
63121 CFR 803.17(a)(1)Lack of System for Event Evaluations
73221 CFR 803.50(a)(2)Individual Report of Malfunction